| Date Filed | Type | Description |
| 10/02/2023 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $1.7, valued at
$3k
|
|
| 08/25/2023 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on Apexigen, Inc.|
Txns:
| Disposed/sold 34,084 options to buy
@ $6.94, valued at
$236.5k
Disposed/sold 100,000 options to buy
@ $2.65, valued at
$265k
|
|
| 08/01/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2023 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 50,000 options to buy
@ $3.55, valued at
$177.5k
Granted 5,895 options to buy
@ $3.55, valued at
$20.9k
|
|
| 06/01/2023 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $3.15, valued at
$5.6k
|
|
| 05/02/2023 |
4
| Smith Scott Andrew (Director) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $3.37, valued at
$6k
|
|
| 04/04/2023 |
4
| Smith Scott Andrew (CEO) has filed a Form 4 on Viatris Inc|
Txns:
| Granted 407,485 restricted stock units
@ $0 |
|
| 04/03/2023 |
4
| Smith Scott Andrew (Former President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $2.68, valued at
$4.8k
|
|
| 03/01/2023 |
4
| Smith Scott Andrew (Former President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $2.98, valued at
$5.3k
Granted 350,000 options to buy
@ $3.65, valued at
$1.3M
|
|
| 02/02/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/03/2023 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $8.25, valued at
$14.8k
|
|
| 12/29/2022 |
3
| Smith Scott Andrew (Director) has filed a Form 3 on Viatris Inc |
| 12/01/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $11.01, valued at
$19.7k
|
|
| 10/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/01/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $8.71, valued at
$15.6k
|
|
| 08/08/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/01/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $3.4, valued at
$6.1k
|
|
| 07/01/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $2.85, valued at
$5.1k
|
|
| 06/03/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $2.41, valued at
$4.3k
|
|
| 05/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/04/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $5, valued at
$9k
|
|
| 03/04/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 1,791 shares
@ $6.48, valued at
$11.6k
|
|
| 02/24/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 200,000 options to buy
@ $6.66, valued at
$1.3M
|
|
| 02/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Paid exercise price by delivering 2,894 shares
@ $19.63, valued at
$56.8k
|
|
| 12/07/2021 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 194 shares
@ $23.997, valued at
$4.7k
Sold 210 shares
@ $24.676, valued at
$5.2k
Sold 74 shares
@ $25.379, valued at
$1.9k
Sold 202 shares
@ $22.186, valued at
$4.5k
Sold 350 shares
@ $23.266, valued at
$8.1k
Sold 76 shares
@ $24.224, valued at
$1.8k
Sold 2,925 shares
@ $21.741, valued at
$63.6k
Sold 59 shares
@ $22.471, valued at
$1.3k
|
|
| 12/06/2021 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 399 shares
@ $23.89, valued at
$9.5k
|
|
| 11/30/2021 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 430 shares
@ $26.235, valued at
$11.3k
Sold 435 shares
@ $24.285, valued at
$10.6k
Sold 249 shares
@ $26.035, valued at
$6.5k
Sold 173 shares
@ $24.053, valued at
$4.2k
Sold 160 shares
@ $24.999, valued at
$4k
Sold 133 shares
@ $25.771, valued at
$3.4k
|
|
| 10/07/2021 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 2,994 shares
@ $30.1775, valued at
$90.4k
|
|
| 08/30/2021 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Sold 19,395 shares
@ $39.6339, valued at
$768.7k
Sold 13,849 shares
@ $40.8858, valued at
$566.2k
|
|
| 06/16/2021 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Acquired 34,963 shares
@ $0 |
|
| 12/17/2020 |
4
| Smith Scott Andrew (President) has filed a Form 4 on BioAtla, Inc.|
Txns:
| Granted 154,943 options to buy
@ $18, valued at
$2.8M
|
|
|